Centene's 2024 Revenue Guidance Has Been Updated To $155B-$157B Versus Prior Guidance Of $147.5B-$150.5B Versus The Consensus Of $149.64B, The 2024 HBR Is Expected To Be At The High End Of The Previous Guidance Range, Approximately 87.9%.
Portfolio Pulse from Benzinga Newsdesk
Centene has updated its 2024 revenue guidance to $155B-$157B, up from the previous $147.5B-$150.5B and above the consensus of $149.64B. The 2024 Health Benefits Ratio (HBR) is expected to be at the high end of the previous guidance range, approximately 87.9%.
July 26, 2024 | 10:42 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Centene has increased its 2024 revenue guidance to $155B-$157B, higher than the previous guidance and consensus estimates. The Health Benefits Ratio (HBR) is also expected to be at the high end of the previous range.
The increase in revenue guidance indicates strong expected performance, which is likely to positively impact investor sentiment and the stock price. The HBR being at the high end of the range also suggests efficient cost management.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100